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Lumbar-disc herniation (LDH), one of the most common musculoskeletal diseases, has strong genetic determinants. Recently, several
genes that encode extracellular matrix (ECM) proteins in the intervertebral disc have been reported to associate with LDH. Thrombo-
spondins (THBSs) 1 and 2 are good candidates for the LDH susceptibility gene: They are intervertebral disc ECM proteins that regulate
the effective levels of matrixmetalloproteinases (MMPs) 2 and 9, which are key effectors of ECM remodeling. Here, we report that THBS2
is associated with LDH in Japanese populations. An intronic SNP in THBS2 (IVS10-8C/ T; rs9406328) showed signiﬁcant association
(p ¼ 0.0000028) with LDH in two independent Japanese populations. This SNP, located in a polypyrimidine tract upstream of the 30
splice site of intron 10, exerts allelic differences on exon 11 skipping rates in vivo, with the susceptibility allele showing increased skip-
ping. Skipping of exon 11 results in decreased THBS2 interaction with MMP2 and MMP9. Further, a missense SNP in MMP9 (Q279R;
rs17576) is also strongly associated with LDH in the Japanese population (p ¼ 0.00049) and shows a combinatorial effect with
THBS2 (odds ratio 3.03, 95% conﬁdence interval 1.58–5.77). Thus, a splicing-affecting SNP in THBS2 and a missense SNP in MMP9
are associated with susceptibility to LDH. Our data indicate that regulation of intervertebral disc ECM metabolism by the THBS2-
MMP system plays an essential role in the etiology and pathogenesis of LDH.Introduction
Lumbar-disc herniation (LDH) is a predominant cause of
low-back pain and unilateral leg pain. Low-back pain
affects 70%–85% of all people during their lifetime, and
LDH is themost common cause of activity limitation in in-
dividuals younger than 45 years of age.1 Twenty percent of
individuals with LDH require surgical treatment to relieve
prolonged or aggravated leg pain.2 Although many risk
factors have been reported for LDH, its etiology and path-
ogenesis are for the most part unknown. The strong famil-
ial predisposition for lumbar-disc degeneration has been
established through a number of family and twin stud-
ies.3–5 Recently, several genes have been reported to associ-
ate with lumbar disc disease. Most encode extracellular
matrix (ECM) proteins in the intervertebral disc, suggest-
ing the importance of ECM metabolism in LDH.6,7
The thrombospondins (THBSs) are a family of ﬁve se-
creted, modular glycoproteins whose functions in the
ECM are diverse and poorly understood.8,9 THBS1 (MIM
188060) and THBS2 (MIM 188061) are structurally more
similar to each other than to THBS3–THBS5 and are, there-
fore, considered to constitute a subfamily.10 Both THBS1
and THBS2 interact with matrix metalloproteinase 21122 The American Journal of Human Genetics 82, 1122–1129, May(MMP2 [MIM 120360]) and 9 (MMP9 [MIM 120361]) and
regulate their effective levels in the pericellular ECM.11,12
Micewith deﬁciencies in eitherThbs1orThbs2 showabnor-
mal spine curvature.13,14 Thbs2 knockout mice also exhibit
increased levels ofMMP2after injury.15 Amore recent study
has shown immunolocalization of THBSs in the human
intervertebral disc.16 These observations prompted us to
examine THBS1 and THBS2 as candidate genes for LDH.
We have identiﬁed a signiﬁcant association between
THBS2 and LDH in Japanese populations. We show that
an associated SNP in THBS2 affects the splicing and conse-
quently alters the binding afﬁnity to MMP2 and MMP9.
We further show MMP9 is also associated with LDH. Our
ﬁndings indicate that THBS2 is involved in LDH through
the regulation of MMP activity in intervertebral-disc ECM.
Material and Methods
Subjects
For the case-control association analysis of LDH, we recruited
525 cases (34.7% female; mean age 5 standard deviation [SD] ¼
41.55 14.9;mean bodymass index (BMI)5 SD¼ 23.15 3.2) and
564 controls (42.4% female; mean age5 SD ¼ 62.45 9.9; mean
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population), and322cases (36.6%female;meanage5SD¼35.75
15.2; mean BMI5 SD ¼ 22.65 3.5) and 332 controls (36.4% fe-
male; mean age 5 SD ¼ 60.9 5 14.1; mean BMI 5 SD ¼ 23.4 5
2.9) for the replication study (Japanese B population). Affected
individuals with LDH were recruited from 19 collaborating hospi-
tals between November 2001 and February 2007. The diagnosis of
LDH required the following three criteria: (1) diagnosis of LDH by
magnetic resonance imaging (sagittal and axial images obtained
with a 1.5-T imaging system), (2) treatment and monitoring for
more than 1 year by orthopedic surgeons, and (3) a history of uni-
lateral pain radiating from the back along the femoral or sciatic
nerve to the corresponding dermatome of the nerve root for a lon-
ger than 3 months. Primary exclusion criteria included synovial
cyst, spinal tumor, spondylolisthesis, spondylosis, trauma, and in-
ﬂammatory disease. From a total of 847 individuals with LDH, 811
underwent surgery for LDH, including posterior discectomy, ante-
rior lumbar interbody fusion, microendoscopic discectomy, and
percutaneous nucleotomy. We extracted genomic DNA from
peripheral blood leukocytes of affected individuals and controls
by using standard protocols. We obtained normal intervertebral
disc tissue from individualswith idiopathic scoliosis during surgery
(seven samples).Written informedconsentwasobtained fromeach
subject as approved by the ethical committees of the SNP Research
Center at RIKEN and participating clinical institutes.
Genotyping
We genotyped SNPs by using themultiplex polymerase chain reac-
tion (PCR)-based Invader assay (Third Wave Technologies),17 Taq-
Man SNP genotyping assays (Applied Biosystems), or by direct se-
quencing of PCR products with ABI 3700 DNA analyzers (Applied
Biosystems) according to the manufacturers’ protocols.
Statistical Analysis
We assessed association and Hardy-Weinberg equilibrium by using
the c2 test. We estimated haplotype frequencies with the expec-
tation-maximization algorithm.18 Linkage disequilibrium coefﬁ-
cients (D’ and r2) were calculated as described previously.7 We
used thepermutation test to adjust signiﬁcance in the analysis of as-
sociation between the THBS2 SNPs and LDH.19 We performed
1,000,000 permutations of the cases and the controls. Detection
of signiﬁcanceof stratiﬁcation (p) andestimationof quantitative as-
sessmentofpopulationstratiﬁcation (l)weredoneaccording topre-
vious reports.20,21We assessed the relationship between the clinical
proﬁles and the genotype information by the Kruskal-Wallis test
and the c2 test. Combinatorial effects of THBS2 andMMP9with re-
gard to LDH susceptibility were also examined as described previ-
ously.22 The odds ratio was deﬁned against the genotype consisting
of homozygotes of nonsusceptibility alleles from both loci.
Cell Culture and RNA Extraction
Fibroblast cells and the human chondrosarcoma cell lines OUMS-
2723 and CS-OKB24 were cultured in Dulbecco’s modiﬁed Eagle’s
medium (DMEM) containing 10% fetal bovine serum (FBS) at
37C under 5% CO2. Total RNA was extracted from tissues and
cells with Isogen (Nippongene) and puriﬁed with SV Total RNA
Isolation System (Promega), according to the manufacturers’
instructions.
RT-PCR and Real-Time PCR
We obtained complementary DNA (cDNA) from all tissues other
than intervertebral disc from Multiple Tissue cDNA Panels (Clon-The Amtech). For the intervertebral disc tissue and cell line, cDNAwas syn-
thesized from total RNA using Multiscribe reverse transcriptase
and oligo-dT primer (Applied Biosystems). We performed quanti-
tative real-time PCR with an ABI PRISM 7700 sequence detector
with the Quantitect SYBR Green PCR Kit (QIAGEN) in accordance
with the manufacturers’ instructions. Primer sequences for reverse
transcriptase (RT)-PCR and real-time PCR are available on request.
Expression of Recombinant Partial Human THBS2
We cloned a cDNA encoding wild-type (WT-THBS2) and exon-11-
skipped partial human THBS2 (Skip-THBS2) into pET42b expres-
sion vectors that had both S tag and GST tag and expressed
them in the E. coli Rosetta (DE3) pLys strain. Recombinant pro-
teins were solubilized from inclusion bodies, renatured with the
Protein Refolding Kit (Novagen), and used for pull-down and
solid-phase binding assays.
Western Blotting
Membranes were blocked with 3% bovine serum albumin in Tris-
buffered saline Tween 20 (TBST). We used polyclonal antibodies
against MMP2 and MMP9 (R&D Systems) at a 1:1000 dilution
in TBST with 1% bovine serum albumin. We used a horseradish
peroxidase (HRP)-conjugated anti-goat immunoglobulin G (IgG)
(Santa Cruz) as the secondary antibody at a 1:7000 dilution in
TBST with 1% bovine serum albumin.
S Protein Pull-down Assay
We incubated S-tagged recombinant THBS2 (5 mM, 20 ml) with 1 mg
of puriﬁed human MMP2 or MMP9 (CHEMICON) for 2 hr at 4C
in 0.3 ml of binding buffer (20 mM Tris-HCl [pH 7.5], 250 mM
NaCl, 1% Triton X-100, and Complete protease inhibitor cocktail
[Roche]). Twelve and a half microliters of S protein agarose (Nova-
gen) was added to the reaction and incubated for 30 min at room
temperature. Precipitates were washed three times with binding
buffer and subjected to 12.5% sodium dodecyl sulfate-polyacryl-
amide gel electrophoresis (SDS-PAGE). We detected coprecipitated
proteins by Western blotting with antibodies to MMP2 or MMP9
(R&D Systems) and S protein HRP conjugate (Novagen).
Solid-Phase Binding Assay
We coatedMaxisorp enzyme-linked immunosorbent assay (ELISA)
plate (Nunc) wells with 50 ml of 0.2 mM GST-tagged recombinant
THBS2 in 100 mM Tris-HCl (pH 7.2) at 4C overnight. We then
blocked the wells with 300 ml of blocking buffer (100 mM Tris-
HCl [pH 7.2], 5 mM CaCl2, 1% bovine serum albumin) for 1 hr
at room temperature, added 50 ml of 4 mg/ml puriﬁed human
MMP2 or MMP9 (CHEMICON) to the wells, and incubated them
for 2 hr at room temperature. Wells were washed twice with 100
mM Tris-HCl (pH 7.2) and incubated with antibodies to MMP2
or MMP9 (R&D Systems). Next, we washed the wells three times
with 100 mM Tris-HCl (pH 7.2) and incubated them with alka-
line-phosphatase-conjugated antibody to goat IgG (ZYMED). After
washing the wells three times with 100 mM Tris-HCl (pH 7.2), we
assayed bound phosphatase activity with the Alkaline Phospha-
tase Substrate Kit (Bio-Rad) and detection at 405 nm.
Results
To conﬁrm the candidacy of THBS1 and THBS2 for LDH,
we examined THBS1 and THBS2 expression in variouserican Journal of Human Genetics 82, 1122–1129, May 2008 1123
human tissues by using real-time RT-PCR.We detected spe-
ciﬁc and high expression levels of both genes in interverte-
bral disc tissue (Figure 1), which further supported the
candidacy of these genes for the LDH-susceptibility gene.
On the basis of information in the HapMap phase II
database (International HapMap Consortium), we selected
SNPs with minor allele frequencies of more than 10% that
covered most haplotypes in the THBS1 and THBS2 genes.
We selected 11 tag SNPs, two in THBS1 and nine in
Figure 1. Real-Time PCR Analysis of THBS1 and THBS2 mRNAs
in Various Human Tissues
THBS1 and THBS2 mRNAs are abundantly expressed in the interver-
tebral disc. Data represent the ratio of THBS mRNAs to beta-actin
(ACTB) mRNA. Error bars represent 5 standard error of the mean
(SEM) (n ¼ 7).1124 The American Journal of Human Genetics 82, 1122–1129, MayTHBS2. Together, these SNPs covered more than 80% of
the alleles in each gene that had an r2 value of 0.8 or
greater. We ﬁrst genotyped the tag SNPs in 188 individuals
with LDH and 188 control individuals. We performed c2
tests for genotype, dominant, recessive, and allele-fre-
quency models and identiﬁed three SNPs in THBS2 show-
ing nominal p values of less than 0.05 in any of the four
models (data available from authors). We found no associ-
ation in THBS1 tag SNPs. Next, we genotyped the nine
THBS2 tag SNPs in additional 337 LDH cases and 376 con-
trols. In a total of 525 cases and 564 controls (Japanese
A population), we found one SNP (rs6422747) that was
signiﬁcantly associated with LDH (Table 1).
To locate the disease-causing sequence variation in
THBS2, we resequenced in and around all exons of the
gene and its promoter sequence (approximately 1 kb) in
24 LDH individuals and identiﬁed a total of 15 sequence
variations other than two tag SNPs. We selected ﬁve of
these by excluding SNPs that were in linkage disequilib-
rium (LD) with the landmark SNP (rs6422747), having an
r2 value of less than 0.1. We genotyped them for the Japa-
nese A population and identiﬁed one SNP (IVS10-8C/ T,
rs9406328) that had the most signiﬁcant association with
LDH (c2 ¼ 16.85, p ¼ 0.000040; comparison of allele
frequency, Table 1). The association was signiﬁcant even
after Bonferroni’s correction of multiple testing (corrected
p ¼ 0.00064).
We estimated LD across the THBS2 region by using gen-
otyping data from control samples (n ¼ 564, data available
from authors). We then examined haplotypes based on the
seven SNPs containing the SNP IVS10-8C/ T. Six haplo-
types with frequencies of more than 0.01 represented
more than 95% of both the case and control populations.
The haplotype associations were far less signiﬁcant than
that of the SNP IVS10-8C/ T alone (Table 2). Therefore,Table 1. Association of SNPs in THBS2 with Lumbar-Disc Herniation
LDH Control Test for Allele Frequency
dbSNP ID Assaya Location 11 12 22 Sum 11 12 22 Sum p Valueb Odds Ratioc (95% CI)
rs7382358 T IVS4 367 142 16 525 342 201 21 564 0.0032 1.38 (1.11–1.72)
rs9379341 T IVS5 266 212 47 525 251 246 67 564 0.023 1.24 (1.03–1.48)
rs13192849 D IVS6 398 114 13 525 377 167 19 563 0.0019 1.45 (1.15–1.83)
rs9283850 T IVS9 396 124 5 525 437 121 5 563 0.42 0.90 (0.70–1.16)
rs9406328 D IVS10 203 243 79 525 164 271 129 564 0.000040 1.43 (1.20–1.70)
rs6940420 T IVS14 360 146 19 525 362 181 19 562 0.24 1.14 (0.92–1.41)
rs6422748 D IVS14 130 266 128 524 195 261 107 563 0.00036 0.74 (0.62–0.87)
rs9505891 D IVS14 275 209 41 525 236 255 73 564 0.000087 1.44 (1.20–1.73)
rs6422747 T IVS14 130 266 128 524 195 261 108 564 0.00043 0.74 (0.62–0.87)
rs11966235 T IVS16 367 140 17 524 390 157 17 564 0.84 1.02 (0.82–1.28)
rs12665573 T IVS17 422 99 4 525 437 117 10 564 0.15 1.22 (0.93–1.59)
rs10945405 T IVS21 162 267 96 525 148 286 128 562 0.035 1.20 (1.01–1.42)
rs9393165 D IVS22 161 267 97 525 148 286 128 562 0.044 1.19 (1.00–1.41)
rs8089 T 30-UTR 424 98 3 525 453 105 5 563 0.81 1.03 (0.78–1.37)
LDH, lumbar-disc herniation; CI, confidence interval. Allele 1 and allele 2 indicate the major and minor allele, respectively.
a T, Tag SNPs; D, SNPs discovered by resequencing.
b Not corrected for multiple testing.
c Odds ratio for allele 1 versus allele 2.2008
Table 2. Association of Haplotypes of the THBS2 Region with Lumbar-Disc Herniation
SNP Haplotype Frequency
rs13192849 rs9283850 rs9406328 rs6940420 rs6422748 rs9505891 rs6422747 LDH Control p Valuea
T T T C C C C 0.489 0.409 0.00017
G T C C G G T 0.130 0.181 0.0010
T T C T G G T 0.139 0.156 0.25
T C T C G C T 0.115 0.106 0.50
T T C C G C T 0.076 0.084 0.50
T T C T G C T 0.022 0.020 0.66
LDH, lumbar-disc herniation.
a Not corrected for multiple testing.we considered the presence of a hidden causal SNP to be
unlikely.
We analyzed potential confounding factors such as age,
BMI, and sex to evaluate for pseudopositive associations
with LDH. There was no signiﬁcant difference in mean
age, BMI, or sex distribution among genotypes of the
SNP IVS10-8C / T, indicating that the SNP IVS10-8C /
T in THBS2 is an independent risk factor of LDH. By using
genomic control methods,20 we also assessed the stratiﬁ-
cation of the Japanese A population by genotyping 24
randomly selected SNPs. The signiﬁcance of stratiﬁcation
(p) and the inﬂation factor (l) were 0.98 and 1.00 (95th
percentile upper bound 1.53), respectively. Because the
maximum factor (the highest c2 statistic/threshold c2 sta-
tistic) in this study is 1.56, it is unlikely that population
stratiﬁcation is the cause of our case-control association
result.
To conﬁrm the association, we genotyped the SNP
IVS10-8C/ T by using an independent Japanese case-con-
trol population consisting of 322 cases and 332 controls
(Japanese B population). Signiﬁcant association was repli-
cated in this population (Table 3). Again, we saw no signif-
icant difference in mean age, BMI, and sex distribution
among genotypes of the SNP IVS10-8C/ T. In total, the
SNP IVS10-8C / T was genotyped in 847 individuals
with LDH and 896 control individuals, and our results
clearly demonstrated a strong association with LDH in
the Japanese population (c2 ¼ 21.79, p ¼ 0.0000028;
comparison of allele frequency, Table 3). The association
was signiﬁcant after Bonferroni’s correction (corrected
p ¼ 0.000045).The AmTo investigate potential effects of the SNP IVS10-8C/ T
on THBS2 transcription, we performed RT-PCR with
CS-OKB and OUMS-27 cells. The genotypes of the SNP
IVS10-8C/ T in these cell lines were C/C and T/T, respec-
tively. Both cell lines contained a 418 bp PCR product in
addition to the expected 592 bp product (Figure 2A).
Sequence analysis revealed that the 418 bp product lacked
exon 11 but retained the original reading frame. Further,
we observed a greater amount of the 418 bp product in
OUMS-27 than in CS-OKB, suggesting potential allelic
differences in the rate of exon 11 skipping.
We followed up this initial observation in vivo by
performing RT-PCR and allele-speciﬁc real-time PCR in
29 normal human ﬁbroblast cell samples. Fourteen of the
samples had the genotype T/T at the SNP IVS10-8C / T
locus, 11 had T/C, and the remaining four had C/C. Our
analysis revealed signiﬁcant association between the geno-
type of the SNP IVS10-8C / T and the rate of exon 11
skipping in vivo (Figures 2B and 2C). The rate of exon 11
skipping for the T/T genotype was approximately 3.8-
fold higher than that of C/C, conﬁrming allelic differences
in THBS2 transcription.
Because exon 11ofTHBS2 encodes one of three THBS type
1 repeat (TSR) domains that interact with MMP2 and
MMP9,11 we examined the effect of exon 11 skipping on
the interaction between THBS2 and MMP2 or MMP9. We
performed immunoprecipitationexperimentswithS-tagged,
recombinant partial human THBS2 proteins produced in E.
coli. Both the wild-type TSR domains (WT-THBS2) and the
exon-11-skipped TSR domains (Skip-THBS2) that lack the
third TSR domain coprecipitated with MMP2 and MMP9Table 3. Association of rs9406328, IVS10-8C/ T, in THBS2 with Lumbar-Disc Herniation
LDH Control
Genotype Genotype Test for Allele Frequency
Population TT TC CC Sum Allele T Frequency TT TC CC Sum Allele T Frequency p Valuea Odds Ratio (95% CI)
Japanese A 203 243 79 525 0.618 164 271 129 564 0.531 0.000040 1.43 (1.20–1.70)
Japanese B 106 173 43 322 0.598 92 170 70 332 0.533 0.018 1.30 (1.05–1.62)
Combinedb 309 416 122 847 0.610 256 441 199 896 0.532 0.0000028 1.38 (1.21–1.58)
LDH, lumbar-disc herniation; CI, confidence interval.
a Not corrected for multiple testing.
b The sum of the two Japanese populations.erican Journal of Human Genetics 82, 1122–1129, May 2008 1125
(Figure 3A). Solid-phase binding assays conﬁrmed that
WT-THBS2 bound to MMP2 or MMP9 more strongly than
did Skip-THBS2 (Figure 3B).
Binding of THBS2 with MMP2 and MMP9 implies
a causal link of MMPs with LDH. Therefore, we evaluated
whether MMP2 and MMP9 also are associated with LDH.
We genotyped 15 tag SNPs in MMP2 and MMP9, selected
with the same criteria as for the THBS genes, in the Japa-
Figure 2. Effects of the LDH-Associated SNP, IVS10-8C/ T,
on THBS2 Exon 11 Splicing In Vivo
(A) Left: RT-PCR products from CS-OKB and OUMS-27 cells repre-
senting the wild-type and exon-11-skipped transcripts. Right:
patterns of exon skipping. Arrows indicate the positions of PCR
primers.
(B) Rates of exon 11 skipping for each genotype, detected by
RT-PCR (top) and allele-specific real-time PCR (bottom). Of the
29 normal human fibroblast cell samples examined (F1-F29), three
representatives for each genotype are shown.
(C) Allelic differences in the rate of exon 11 skipping in 29 normal
human fibroblast cells, detected by allele-specific real-time PCR.
Data represent the mean5 SEM. ** indicates p < 0.01 (Student’s
t test).1126 The American Journal of Human Genetics 82, 1122–1129, Maynese A population (525 individuals with LDH and 564
controls). One missense SNP (Q279R, rs17576) in MMP9
was strongly associated with LDH (Table 4). MMP2 tag
SNPs did not show any signiﬁcant association. We rese-
quenced in and around all exons of MMP9 and its
promoter sequence (approximately 1 kb) in 24 LDH indi-
viduals and identiﬁed a total of nine sequence variations.
We genotyped the landmark SNP (rs17576) and other
two SNPs that were in LD with the landmark SNP in 847
LDH cases and 896 controls (Japanese A and Japanese B
populations). We found the most signiﬁcant association
in the landmark SNP (combined p ¼ 0.00049; comparison
for allele frequency, Table 4), which was signiﬁcant even
after Bonferroni’s correction (corrected p ¼ 0.0083).
The functional relationship between THBS2 and MMP9
raises the possibility of a combinatorial effect of these
genes in LDH. We examined this possibility by combining
genotype data on a pair of loci in 847 cases and in 896
controls. Signiﬁcant combinatorial association was ob-
served for THBS2 (rs9406328) and MMP9 (rs17576) with
LDH. The genotype that was homozygous with respect to
Figure 3. Effects of Exon 11 Skipping on the Interaction of
THBS2 with MMP2 and MMP9 In Vitro
(A) S protein pull-down assay. S-tagged recombinant human THBS2
was incubated with purified human MMP2 (left) or MMP9 (right).
MMP2 and MMP9 were detected with antibodies, and S-tagged
THBS2 was detected with S protein HRP conjugate.
(B) Solid-phase binding assay. Microplate wells coated with GST or
GST-tagged recombinant human THBS2 were incubated with
or without purified human MMP2 (left) or MMP9 (right). Binding
of GST-tagged THBS2 to MMP2 or MMP9 was quantified by colori-
metric assay at A405 nm. Data represent the mean5 SEM in quadru-
plicate assays. ** indicates p < 0.01 (Student’s t test). NC
indicates noncoated.2008
Table 4. Association of rs17576, Q279R, in MMP9 with Lumbar-Disc Herniation
LDH Control
Genotype Genotype Test for Allele Frequency
Population GG GA AA Sum Allele G Frequency GG GA AA Sum Allele G Frequency p Valuea Odds Ratio (95% CI)
Japanese A 265 203 57 525 0.698 234 250 80 564 0.637 0.0023 1.32 (1.10–1.58)
Japanese B 154 133 35 322 0.685 142 140 50 332 0.639 0.077 1.23 (0.98–1.55)
Combinedb 419 336 92 847 0.693 376 390 130 896 0.637 0.00049 1.29 (1.12–1.48)
LDH, lumbar-disc herniation; CI, confidence interval.
a Not corrected for multiple testing.
b The sum of the two Japanese populations.susceptible alleles of both SNPs showed the highest odds
ratio (3.03; 95% conﬁdence interval ¼ 1.58-5.77, Table 5).
Discussion
Our genetic and functional data indicate that THBS2 is
involved in LDH via the regulation ofMMPs in the interver-
tebral disc ECM.MMP2 andMMP9 activities aremainly reg-
ulated by endocytosis, a general clearance mechanism for
ECM. Endocytic clearance ofMMPs ismediated by the scav-
enger receptor, low-density lipoprotein receptor-related
protein (LRP).25,26 THBS2 promotes LRP-mediated endocy-
tosis of MMP2 and its subsequent lysosomal degradation.25
Thus, THBS2 may play a major role in intervertebral disc
ECM homeostasis as a modulator of MMP2 and MMP9
endocytosis.
MMP activity is also regulated at different levels with
activation of the latent enzyme and inhibition by tissue
inhibitor of metalloproteinase (TIMP). MMP2 and MMP9
mostly exist in tissues as latent enzymes that make com-
plexes to their speciﬁc inhibitors, TIMP2 (MIM 188825)
and TIMP1 (MIM 305370), respectively.27,28 TheseMMP in-
hibitors, aswell asotherMMPregulators, couldalsobeacan-
didate for LDH-susceptibility genes, although the clearance
ofMMP2-TIMP2 complex is THBS2-independent process.29
Our ﬁndings suggest that the third TSR in THBS2 plays
an important role in its interaction with MMPs and in
LDH pathogenesis overall. TSRs are small cystein-knot
modules of approximately 60 amino acids, containing six
conserved cystein residues as well as conserved trypto-
phan, serine, and arginine residues.30 The TSR domain ofThe AmTHBS2 consists of three repeats and interacts with MMP2
and MMP9.11 These three repeats share conserved cystein
and tryptophan residues but differ in other amino acid
positions, suggesting that each repeat functions differ-
ently. Several short motifs within TSRs have been reported
to support protein-protein interactions.31,32
The susceptibility SNP in MMP9 (Q279R) resides within
the highly conserved gelatinase-speciﬁc ﬁbronectin type
II domains, which presumably enhance substrate bind-
ing.33,34 This SNP has previously been reported to associate
with metastasis of lung cancer35 and trachoma;36 however,
its function is unknown.We can hypothesize that this non-
conservative amino acid change affects enzyme activity by
modifying its substrate binding capacity. Further character-
ization of the interaction between THBS2 and MMPs, as
well as the identiﬁcation of other genes functioning within
this metabolic pathway, should reveal promising targets for
treatment and novel therapeutic strategies for LDH.
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GG 154 213 52 105 193 78 3.03 (1.58–5.77) 2.28 (1.21–4.27) 1.38 (0.69–2.75)
GA 123 159 54 116 186 88 2.19 (1.14–4.18) 1.76 (0.94–3.32) 1.27 (0.64–2.51)
AA 32 44 16 35 62 33 1.89 (0.88–4.06) 1.46 (0.72–2.98) 1
LDH, lumbar-disc herniation; CI, confidence interval.erican Journal of Human Genetics 82, 1122–1129, May 2008 1127
Web Resources
The URLs for data presented herein are as follows:
Applied Biosystems, http://www.appliedbiosystems.com/index.
cfm
International HapMap Project, http://hapmap.org/
Online Mendelian Inheritance in Man (OMIM), http://www.ncbi.
nlm.nih.gov/Omim/
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